Parallel Advisors, LLC Moderna, Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,347 shares of MRNA stock, worth $133,110. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,347

Previous 4,249 21.23%

Holding current value

$133,110

Previous $504,000 55.75%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $57,403 - $112,876	-902 Reduced 21.23%	3,347 $223,000
Q2 2024 Aug 08, 2024	SELL	$101.21 - $166.61 $117,707 - $193,767	-1,163 Reduced 21.49%	4,249 $504,000
Q1 2024 May 06, 2024	BUY	$85.37 - $115.44 $138,640 - $187,474	1,624 Added 42.87%	5,412 $576,000
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $133,598 - $200,714	-1,922 Reduced 33.66%	3,788 $376,000
Q3 2023 May 20, 2024	SELL	$96.41 - $126.61 $24,102 - $31,652	-250 Reduced 4.19%	5,710 $589,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $24,102 - $31,652	-250 Reduced 4.19%	5,710 $589,000
Q2 2023 May 20, 2024	SELL	$118.5 - $160.53 $60,198 - $81,549	-508 Reduced 7.85%	5,960 $724,000
Q2 2023 Aug 04, 2023	SELL	$118.5 - $160.53 $60,198 - $81,549	-508 Reduced 7.85%	5,960 $724,000
Q1 2023 May 20, 2024	BUY	$135.66 - $197.02 $143,256 - $208,053	1,056 Added 19.51%	6,468 $993,000
Q1 2023 Apr 25, 2023	SELL	$135.66 - $197.02 $43,818 - $63,637	-323 Reduced 4.76%	6,468 $993,000
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $24,741 - $43,898	209 Added 3.18%	6,791 $1.22 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $91,031 - $149,712	-771 Reduced 10.49%	6,582 $778,000
Q2 2022 Aug 01, 2022	SELL	$117.13 - $176.59 $48,374 - $72,931	-413 Reduced 5.32%	7,353 $1.05 Million
Q1 2022 Apr 28, 2022	BUY	$126.46 - $235.05 $50,457 - $93,784	399 Added 5.42%	7,766 $1.36 Million
Q4 2021 Jan 20, 2022	BUY	$225.82 - $368.51 $275,726 - $449,950	1,221 Added 19.87%	7,367 $1.87 Million
Q3 2021 Nov 02, 2021	BUY	$221.9 - $484.47 $618,435 - $1.35 Million	2,787 Added 82.97%	6,146 $2.37 Million
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $8,703 - $15,743	67 Added 2.04%	3,359 $789,000
Q1 2021 Apr 23, 2021	BUY	$109.18 - $185.98 $185,933 - $316,723	1,703 Added 107.17%	3,292 $431,000
Q4 2020 Feb 02, 2021	BUY	$65.74 - $169.86 $39,706 - $102,595	604 Added 61.32%	1,589 $166,000
Q3 2020 Oct 27, 2020	BUY	$54.34 - $94.85 $15,595 - $27,221	287 Added 41.12%	985 $70,000
Q2 2020 Jul 16, 2020	BUY	$29.67 - $80.0 $1,542 - $4,160	52 Added 8.05%	698 $44,000
Q1 2020 Apr 27, 2020	SELL	$17.78 - $31.58 $26,598 - $47,243	-1,496 Reduced 69.84%	646 $19,000
Q4 2019 Jan 30, 2020	BUY	$13.93 - $21.28 $1,978 - $3,021	142 Added 7.1%	2,142 $42,000
Q3 2019 Nov 01, 2019	SELL	$12.26 - $18.07 $14,712 - $21,684	-1,200 Reduced 37.5%	2,000 $32,000
Q2 2019 Aug 05, 2019	SELL	$13.7 - $28.34 $95,215 - $196,963	-6,950 Reduced 68.47%	3,200 $47,000
Q1 2019 May 01, 2019	BUY	$14.45 - $23.7 $146,667 - $240,555	10,150 New	10,150 $207,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

9.93M

Put Options Held

17.6M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Moderna, Inc. Transaction History